Literature DB >> 17512417

Use of device diagnostics in the outpatient management of heart failure.

Robin Germany1, Christina Murray.   

Abstract

Implantable cardiac devices now go far beyond the functionality of early pacemakers and defibrillators. They provide us with an unprecedented amount of information about the day-to-day status of our patients with heart failure, providing insight into the complex clinical picture of these patients. More advanced technology can be seen on the horizon, and the development of strategies to incorporate this information into our clinics is needed. Traditionally, information from devices has only been accessed by the physicians implanting the device. However, heart failure physicians and their patients can benefit from the information now available and from having ways to access and use the data. This article focuses on the successful integration of device-based data into patient care in the outpatient clinical setting.

Entities:  

Mesh:

Year:  2007        PMID: 17512417     DOI: 10.1016/j.amjcard.2007.02.037

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Remote monitoring of implanted cardiac devices: a plea for a nationwide exploration.

Authors:  N M van Hemel
Journal:  Neth Heart J       Date:  2009-11       Impact factor: 2.380

2.  Exploring time series retrieved from cardiac implantable devices for optimizing patient follow-up.

Authors:  Marie Guéguin; Emmanuel Roux; Alfredo I Hernández; Fabienne Porée; Philippe Mabo; Laurence Graindorge; Guy Carrault
Journal:  IEEE Trans Biomed Eng       Date:  2008-10       Impact factor: 4.538

3.  Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.

Authors:  Stefan Sack; Christian Michael Wende; Herbert Nägele; Amos Katz; Wolfgang Rudolf Bauer; Craig Scott Barr; Klaus Malinowski; Harald Schwacke; Francisco Leyva; Jochen Proff; Sergey Berdyshev; Vincent Paul
Journal:  Eur J Heart Fail       Date:  2011-09       Impact factor: 15.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.